A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis - PubMed (original) (raw)

Clinical Trial

. 1989 May;102(5):327-32.

• PMID: 2509153

Clinical Trial

A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis

X L Tao et al. Chin Med J (Engl). 1989 May.

Abstract

A polyglycosides of Tripterygium wilfodii hook F (TWH) preparation with a code name of T2 is used in the present double-blind, controlled, cross-over study on the treatment of 70 cases of rheumatoid arthritis (RA). An impressive curative effect of T2 is confirmed much more convincingly by the present study than that by the previously reported clinical open trials. The adverse reactions and the probable pharmacological mechanism of T2 are also discussed.

PubMed Disclaimer

Similar articles

• [A double-blind study of T2 (tablets of polyglycosides of Tripterygium wilfodii hook) in the treatment of rheumatoid arthritis].
  Tao XL, Dong Y, Zhang NZ. Tao XL, et al. Zhonghua Nei Ke Za Zhi. 1987 Jul;26(7):399-402, 444-5. Zhonghua Nei Ke Za Zhi. 1987. PMID: 3322706 Clinical Trial. Chinese. No abstract available.
• Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study.
  Tao X, Younger J, Fan FZ, Wang B, Lipsky PE. Tao X, et al. Arthritis Rheum. 2002 Jul;46(7):1735-43. doi: 10.1002/art.10411. Arthritis Rheum. 2002. PMID: 12124856 Clinical Trial.
• A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
  Tao X, Cush JJ, Garret M, Lipsky PE. Tao X, et al. J Rheumatol. 2001 Oct;28(10):2160-7. J Rheumatol. 2001. PMID: 11669150 Clinical Trial.
• A potential new treatment for rheumatoid arthritis: thunder god vine.
  Lipsky PE, Tao XL. Lipsky PE, et al. Semin Arthritis Rheum. 1997 Apr;26(5):713-23. doi: 10.1016/s0049-0172(97)80040-6. Semin Arthritis Rheum. 1997. PMID: 9144848 Review.

Cited by

• Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
  Huang M, Zhang H, Liu T, Tian D, Gu L, Zhou M. Huang M, et al. Mol Cancer Ther. 2013 Feb;12(2):184-94. doi: 10.1158/1535-7163.MCT-12-0425. Epub 2012 Dec 12. Mol Cancer Ther. 2013. PMID: 23243057 Free PMC article.
• Triptolide inhibits TGF-β-induced matrix contraction and fibronectin production mediated by human Tenon fibroblasts.
  Liu Y, Liu PP, Liu L, Zheng XS, Zheng H, Yang CC, Luobu CR, Liu Y. Liu Y, et al. Int J Ophthalmol. 2018 Jul 18;11(7):1108-1113. doi: 10.18240/ijo.2018.07.06. eCollection 2018. Int J Ophthalmol. 2018. PMID: 30046525 Free PMC article.
• The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages.
  Bao X, Cui J, Wu Y, Han X, Gao C, Hua Z, Shen P. Bao X, et al. J Mol Med (Berl). 2007 Jan;85(1):85-98. doi: 10.1007/s00109-006-0113-x. Epub 2006 Nov 16. J Mol Med (Berl). 2007. PMID: 17109129
• Development of B cells and erythrocytes is specifically impaired by the drug celastrol in mice.
  Kusy S, Ghosn EE, Herzenberg LA, Contag CH. Kusy S, et al. PLoS One. 2012;7(4):e35733. doi: 10.1371/journal.pone.0035733. Epub 2012 Apr 24. PLoS One. 2012. PMID: 22545133 Free PMC article.
• Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells.
  Carter BZ, Mak DH, Schober WD, McQueen T, Harris D, Estrov Z, Evans RL, Andreeff M. Carter BZ, et al. Blood. 2006 Jul 15;108(2):630-7. doi: 10.1182/blood-2005-09-3898. Epub 2006 Mar 23. Blood. 2006. PMID: 16556893 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information